Correlation Between Korean Drug and MEDIPOST

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Korean Drug and MEDIPOST at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and MEDIPOST into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korean Drug Co and MEDIPOST Co, you can compare the effects of market volatilities on Korean Drug and MEDIPOST and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of MEDIPOST. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and MEDIPOST.

Diversification Opportunities for Korean Drug and MEDIPOST

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Korean and MEDIPOST is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and MEDIPOST Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEDIPOST and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with MEDIPOST. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEDIPOST has no effect on the direction of Korean Drug i.e., Korean Drug and MEDIPOST go up and down completely randomly.

Pair Corralation between Korean Drug and MEDIPOST

Assuming the 90 days trading horizon Korean Drug Co is expected to generate 0.36 times more return on investment than MEDIPOST. However, Korean Drug Co is 2.81 times less risky than MEDIPOST. It trades about -0.07 of its potential returns per unit of risk. MEDIPOST Co is currently generating about -0.24 per unit of risk. If you would invest  492,755  in Korean Drug Co on October 17, 2024 and sell it today you would lose (15,255) from holding Korean Drug Co or give up 3.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Korean Drug Co  vs.  MEDIPOST Co

 Performance 
       Timeline  
Korean Drug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Korean Drug is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
MEDIPOST 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in MEDIPOST Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MEDIPOST sustained solid returns over the last few months and may actually be approaching a breakup point.

Korean Drug and MEDIPOST Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Korean Drug and MEDIPOST

The main advantage of trading using opposite Korean Drug and MEDIPOST positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, MEDIPOST can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEDIPOST will offset losses from the drop in MEDIPOST's long position.
The idea behind Korean Drug Co and MEDIPOST Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Valuation
Check real value of public entities based on technical and fundamental data